PLEURAL DISEASE UNIT
Pleural disease affects 60,000 patients a year in Australia. Pleural malignancies and infections are the commonest causes of exudative pleural effusions, and their incidence, mortality and health-care costs continue to rise. The Pleural Diseases Unit is regarded as one of the most active pleural research groups in the world, and uniquely combines a clinical and a laboratory arm closely integrated with the most active tertiary pleural services in Australasia.
The program focuses on translational research in common pleural diseases, especially cancer and infection, with a strong publication record on clinical (phase I to multicentre randomised trials) and bench research (molecular biology to animal models) as well as novel diagnostic and management strategies for pleural effusions. Much of the research work has directly impacted clinical practice and helped reduce patient mortality and morbidity in malignant effusion (eg setting up of the indwelling catheter services in WA) and pleural infection (eg introduction of the new intrapleural therapy).
Prof Y C Gary Lee is a recognized opinion leader in pleural diseases with proven research successes in the USA and the UK, prior to relocating to Australia in 2009. He has an established publication (over 130 papers) and grant (over $7 million) record. He has delivered over 100 invited lectures in 25 countries, co-edited international guidelines and reference texts on pleural diseases, and have trained many fellows/PhD students from around the world.